homoarginine has been researched along with Glaucoma, Suspect in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Connor, JR; Das, S; Gachie, E; Kawai, S; Manning, PT; Neufeld, AH; Vora, S | 1 |
1 other study(ies) available for homoarginine and Glaucoma, Suspect
Article | Year |
---|---|
A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma.
Topics: Administration, Oral; Animals; Cell Count; Cell Survival; Disease Models, Animal; Enzyme Inhibitors; Glaucoma; Homoarginine; Intraocular Pressure; Male; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ocular Hypertension; Prodrugs; Rats; Rats, Inbred BN; Retinal Ganglion Cells | 2002 |